Reference - Detail
| RRC ID | 72998 |
|---|---|
| Author | Sakagami H, Amano S, Uota S, Tanuma SI, Inomata M, Shindo A, Kusano M, Kikkawa Y, Horiuchi M, Ooka T. |
| Title | Prominent Anti-UVC Activity of Lignin Degradation Products. |
| Journal | In Vivo |
| Abstract |
BACKGROUND/AIM:The rapid spread of COVID-19 resulted in the revision of the value of ultraviolet C (UVC) sterilization in working spaces. This study aimed at re-evaluating the anti-UVC activity of four groups of natural products against human melanoma COLO679 and human normal dermal fibroblast (HDFa) cells, based on chemotherapeutic index. MATERIALS AND METHODS:Various cell lines were exposed to UVC for 3 min in the presence of increasing concentrations of test compounds and viable cell numbers were determined with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The anti-UVC activity was quantified by the ratio of the 50% cytotoxic concentration (determined without irradiation) to the 50% effective concentration (which abolished by 50% the UVC-induced loss of viability). Apoptosis was quantified as the subG1 population proportion following cell-cycle analysis. RESULTS:Among four groups of major natural products, six phenylpropanoids showed the highest anti-UVC activity, followed by the lignified products and alkaline products that contain lignin and its degradation products. On the other hand, tannins and flavonoids showed lower activity due to their higher cytotoxicity. UVC-sensitive COLO679 cells lack dectin-1 protein expression. CONCLUSION:These data suggest the prominent anti-UVC activity of lignin degradation products, and the possible involvement of dectin-1 expression in UVC-sensitivity. |
| Volume | 36(6) |
| Pages | 2689-2699 |
| Published | 2022-1-1 |
| DOI | 10.21873/invivo.13004 |
| PII | 36/6/2689 |
| PMID | 36309360 |
| MeSH | Biological Products* / pharmacology COVID-19* Humans Lignin / pharmacology Melanoma* Ultraviolet Rays |
| IF | 1.541 |
| Resource | |
| Human and Animal Cells | COLO 679(RCB0989) |